Floyd Robert Michael 4
4 · Processa Pharmaceuticals, Inc. · Filed Oct 8, 2021
Insider Transaction Report
Form 4
Floyd Robert Michael
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2021-10-06−4,663→ 9,387 total - Exercise/Conversion
Common Stock
2021-10-06+12,500→ 14,500 total
Holdings
- 117,409(indirect: by Elion Oncology, Inc.)
Common Stock
Footnotes (1)
- [F1]Vesting of restricted stock.